Antiviral Cocktail Highly Effective in At-Risk Covid Patients

Treatment with Regeneron’s two-drug antibody cocktail of casirivimab and imdevimab was associated with a roughly 70% reduction in the risk for hospitalization or death among outpatients with Covid-19 at increased risk for developing severe disease.